Year: 2023

ImmunoScape_-_Logo_-_Color_-_Final

ImmunoScape Uses Machine Learning to Accurately Predict Antigen Specificity Based on T-Cell Phenotypes in New Peer-Reviewed Research

ImmunoScape’s platform accelerates the discovery of efficacious TCR-based therapeutics for solid tumors SAN DIEGO & SINGAPORE--(BUSINESS WIRE)--ImmunoScape, a biotechnology company...

EWB_Logo_Sm_Eng_Tag_Horz_Pos_RGB-2

East West Bancorp Reports Net Income for Third Quarter of 2023 of $288 Million and Diluted Earnings Per Share of $2.02; Record Third Quarter Revenue and Net Interest Income

PASADENA, Calif.--(BUSINESS WIRE)--East West Bancorp, Inc. (“East West” or the “Company”) (Nasdaq: EWBC), parent company of East West Bank, reported...

Endeavor_Logo

Endeavor BioMedicines Enters License Agreement with Hummingbird Bioscience for Worldwide Rights to HMBD-501, a Next Generation HER3-Targeted Antibody-Drug Conjugate (ADC)

Endeavor obtains exclusive worldwide rights to Hummingbird Bioscience’s anti-HER3 ADC to be developed for patients with HER3-expressing tumors Hummingbird Bioscience...

Logo_Pernod_Ricard

CORRECTING and REPLACING: Pernod Ricard: Soft Start to the Year on High Comparison Basis With Organic Sales Decline -2% and -8% Reported Strong Price/mix Effect +7%

PARIS--(BUSINESS WIRE)--Regulatory News: Pernod Ricard (Paris:RI): Press release - Paris, 19 October 2023 This replaces the announcement made at 07:30...